Longeveron (LGVN) Other Operating Expenses (2020 - 2024)

Longeveron (LGVN) recorded quarterly Other Operating Expenses of -$100000.0 in Q3 2024, little changed quarter-over-quarter from -$100000.0 in Q2 2024, and down 281.82% on a YoY basis from $55000.0 in Q4 2023.

Longeveron (LGVN) Other Operating Expenses (2020 - 2024) Analysis & Trends

Longeveron's Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$100000.0 for Q3 2024.

  • In Q3 2024, Other Operating Expenses fell 281.82% year-over-year to -$100000.0; the TTM figure through Jun 2025 stood at -$100000.0 (down 122.22% YoY), while the FY2025 annual figure was -$97000.0, changed N/A from the prior year.
  • Other Operating Expenses was -$100000.0 for Q3 2024 at Longeveron, roughly flat from -$100000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $1.1 million in Q4 2021 to a low of -$1.4 million in Q2 2022.
  • Historically, Other Operating Expenses has averaged $59812.5 across 5 years, with a median of $51500.0 in 2020.
  • The sharpest annual moves came in 2021 and 2022: Other Operating Expenses jumped 1733.9% in 2021, then slumped 2747.17% in 2022.
  • A 5-year view of Other Operating Expenses shows it stood at $59000.0 in 2020, then surged by 1733.9% to $1.1 million in 2021, then plunged by 73.66% to $285000.0 in 2022, then tumbled by 80.7% to $55000.0 in 2023, then slumped by 281.82% to -$100000.0 in 2024.
  • The last three Other Operating Expenses figures came in at -$100000.0 (Q3 2024), -$100000.0 (Q2 2024), and $55000.0 (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00

Historic Data

Download Data
DateValue
Sep 30, 2024 -100,000.00
Jun 30, 2024 -100,000.00
Sep 30, 2023 55,000.00
Jun 30, 2023 80,000.00
Dec 31, 2022 285,000.00
Sep 30, 2022 -57,000.00
Jun 30, 2022 -1.40 Mn
Mar 31, 2022 287,000.00
Dec 31, 2021 1.08 Mn
Sep 30, 2021 25,000.00
Jun 30, 2021 53,000.00
Mar 31, 2021 550,000.00
Dec 31, 2020 59,000.00
Sep 30, 2020 44,000.00
Jun 30, 2020 47,000.00
Mar 31, 2020 50,000.00